Emily Lynch
Family Medicine · Caryville, TNNPI 1326498650
Payments from drug & device makers
Across 78 payments — averaging $17.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$284
- Novo Nordisk$256
- Lilly USA, LLC$211
- Axsome Therapeutics, Inc.$158
- AstraZeneca$48
- Bayer$46
- plus $348 from 16 others
What the payments were for
- Food & beverage$1,30597%
- Education$453%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 18 | $284 |
| Novo Nordisk | 14 | $256 |
| Lilly USA, LLC | 11 | $211 |
| Axsome Therapeutics, Inc. | 9 | $158 |
| AstraZeneca | 3 | $48 |
| Bayer | 2 | $46 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $36 |
| Exact Sciences | 2 | $33 |
| Currax Pharmaceuticals LLC | 2 | $32 |
| Abbott | 2 | $31 |
| Amgen | 1 | $20 |
| Philips North America LLC | 1 | $19 |
| Boehringer Ingelheim | 1 | $17 |
| Medtronic | 1 | $17 |
| Pfizer | 1 | $16 |
| Organon | 1 | $16 |
| Gilead | 1 | $16 |
| GSK | 1 | $15 |
| Astellas Pharma US Inc | 1 | $15 |
| Intra-sana Laboratories | 1 | $14 |
| Ironshore Pharmaceuticals Inc. | 1 | $13 |
How this compares
$1,350 in reported general payments places this provider in the 60th percentile of 2,087 family medicine providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 74 | $89,562 |
| VraylarCariprazine Hcl | 51 | $78,954 |
| TrulicityDulaglutide | 61 | $71,373 |
| OzempicSemaglutide | 62 | $67,896 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 88 | $60,481 |
| FarxigaDapagliflozin Propanediol | 75 | $59,359 |
| EliquisApixaban | 39 | $43,234 |
| JanuviaSitagliptin Phosphate | 32 | $36,481 |
| JardianceEmpagliflozin | 39 | $34,196 |
| XifaxanRifaximin | 11 | $32,849 |
| RybelsusSemaglutide | 29 | $30,930 |
| LinzessLinaclotide | 35 | $25,945 |
| XareltoRivaroxaban | 14 | $20,689 |
| Nurtec OdtRimegepant Sulfate | 17 | $19,942 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 25 | $16,003 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $211 | $163,674152 claims |
| AbbVieVraylar, Linzess | $284 | $104,89986 claims |
| Novo NordiskOzempic, Rybelsus | $256 | $98,82591 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $48 | $79,688118 claims |
| PfizerEliquis, Nurtec Odt | $16 | $63,17656 claims |
| GSKTrelegy Ellipta | $15 | $60,48188 claims |
| Boehringer IngelheimJardiance | $17 | $34,19639 claims |
| BayerKerendia | $46 | $10,23412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,087 family medicine providers in Tennessee.
Other family medicine in Caryville
- Rickey ManningKnoxville$8.1M
- Kymberly MoyerGallatin$5.9M
- Natasha BallardChattanooga$5.7M
- Hina BudhwaniNashville$4.7M
- Paul WakefieldKnoxville$4.3M
- Emily HubbsKingsport$2.8M
- Jerry PunchKnoxville$2.1M
- Bridgette FraneyNashville$2M
- Andrew BrockmyreBristol$1.8M
- Marcus LeeTullahoma$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.